Opko Health, Inc.

  • This Biotech Stock Looks Great for the Long Run

    By Terry Chrisomalis - June 30, 2013 | Tickers: MRK, OPK, PFE

    When you are looking to add a biotech stock to your portfolio, most of the small cap biotech stocks have a small-sized pipeline. Also, the small cap biotechs tend to target one area; for example, they may only target cancer. This brings up a biotech that will have substantial value in the future. This biotech company is known as Opko Health (NYSE: OPK) which has diversified itself in targeting many more »

  • This Acquisition Offers a Major Arbitrage Opportunity, But Conditions Apply

    By Mike Thiessen - June 6, 2013 | Tickers: OPK, PBTH, TEVA

    In late April, biotechnology firm Opko Health (NYSE: OPK) announced that it would acquire Israeli pharmaceutical start-up PROLOR Biotech (NYSEMKT: PBTH) in a stock-for-stock deal that currently offers a substantial arbitrage premium. Investors have every right to be interested in this deal. In addition to some exciting operational synergies, it offers one of the clearest merger arbitrage opportunities seen in the past 12 months.

    However, this proposed merger is not more »

  • 2 Stocks to Buy, 1 to Hold

    By Mohsin Saeed - June 6, 2013 | Tickers: HNSN, OPK, PACB

    Insider buying is widely considered a positive indicator for any company. This holds truer for biotechnology companies because valuations are linked to pipeline candidates. The insiders have the most information about the progress of these candidates along with other vital information about the company.

    However, insider buying can also mislead investors into making investments at inopportune moments. Therefore, it is important to view insiders buys in combination with other fundamental more »

  • Investing in Pharmaceuticals? Ask Phillip Frost

    By Anh HOANG - April 15, 2013 | Tickers: BMY, OPK, TEVA

    Insiders always know about their company much better than retail investors do. That's why it is wise for us to watch recent insider trading activity closely besides the company’s fundamentals. Since the beginning of April, Dr. Phillip Frost, CEO and Chairman of Opko Health (NYSE: OPK), has accumulated nearly 570,000 shares of the company at a total transaction value of more than $4 million.

    Interestingly, Dr. Frost more »

  • Opko's Massive Insider Buys: Should Investors Follow Suit?

    By Alex Bastardas - March 7, 2013 | Tickers: ALNY, MRK, OPK

    "There are many reasons for an insider to sell a stock, but only one to buy it: he expects to make money." So goes the saying. Many investors invest their time in tracking insider transactions, as it is assumed that a company insider probably has some unique insights into the company's business, and likely expects those shares to go up in the future. If that's true, then Dr more »

  • Why Are Insiders Purchasing This Biotech Stock?

    By Shas Dey - January 24, 2013 | Tickers: OPK, UTHR

    Insiders purchase stocks for a variety of reasons. One reason could be that insiders are the ones most familiar with the company's everyday operations and its future prospects. Any such purchase could be viewed as a signal that the stock is expected to perform admirably in the future. This could both be genuine buying by the insider in order to benefit from the stock’s performance or just a more »

  • Two Biotech Growth Stocks from a Resource Investor’s Perspective

    By Streetwise Reports - January 16, 2013 | Tickers: OPK

    By George S. Mack of The Life Sciences Report

     

    Michael Berry is known to investors as a small- and micro-cap natural resources expert and Discovery Investing publisher who understands the importance of good management and how it can make a bundle for growth seekers. Now, he’s turning some of his attention to the life sciences sector where he is also enjoying some successes. It was with a great deal more »

  • Are These Going to Be the Big Winners of 2013?

    By Brian Gorban - January 7, 2013 | Tickers: AMGN, OPK, SONS

    As any investor will tell you, being able to consistently outperform the market is no easy feat whatsoever. One strategy that has proven to be effective over time in determining whether a stock is moving higher is insider accumulation due to one simple reason: Insiders buy shares, just like us, to make more money. Furthermore, they have an enviable vantage point of the day-to-day operations of the company and/or more »

  • New Test Can Boost Revenues Tenfold, One Insider Is Buying

    By Meena Krishnamsetty - December 20, 2012 | Tickers: EW, MXDHF, OPK, WAT

    Each year, there are around 200,000 distinct insider transactions reported to SEC via Form 4 filings. While the term "insider trading" sounds nefarious, there are just a handful of cases deemed illegal by federal prosecutors each year, though anomalous, above-average returns remain.

    On average, a host of empirical studies and our own research have found that individuals who mimic certain insider trades can beat the market by 7 percentage more »

  • Personalized Diagnostic Medicine Coming of Age

    By Streetwise Reports - December 6, 2012 | Tickers: EXAS, GHDX, OPK

    By George S. Mack of The Life Sciences Report.

    For more interviews with sector experts and analysts, please sign up for our newsletter at www.thelifesciencesreport.com.

    As little as a decade ago we were all thinking in terms of one blood draw being the be-all and end-all of diagnostics. With the first human genome sequenced, it would only require a panel of genetic, epigenetic, proteomic and small molecule metabolic more »

  • Insider Siren: Should we Accumulate These Stocks as well?

    By Brian Gorban - October 17, 2012 | Tickers: ABT, BRK-B, DVA, OPK

    The stock market and investing in general has its way of humbling even the best investors as nobody has proven to have a method that is truly infallible. However, one method that has proven to be useful in determining whether a stock is moving higher is insider buying due to one simple reason: insiders accumulate shares, just like the common investor, to make more money. Furthermore, insiders arguably are able more »

  • Opko Health - Look Beyond the Diagnostic Tests

    By Jordo Bivona - October 4, 2012 | Tickers: OPK, PFE, TEVA

    Opko Health (NYSE: OPK), a multinational pharmaceutical and diagnostic company, is now among the most highly shorted stocks on the NYSE, according to a recent article in Barron's.

    Dr. Phillip Frost's name is well-known throughout metropolitan Miami due to his philanthropy and endowments at educational and cultural facilities. And what Frost has touched has generally turned to gold though his professional life. The billionaire is now chairman of more »

  • 5 Stocks with Bullish Insider Sentiment

    By Meena Krishnamsetty - October 2, 2012 | Tickers: EGL, JNS, NATR, OPK, WPP

    Being informed of what insiders are doing with their company’s stock—whether it be buying or selling—can be predictive of how a company might perform in the future. Insiders generally have the most knowledge about a company and it is usually a bullish sign when an insider forgoes diversification to invest more money into the company he/she works for. Academic research has show that insider purchases are more »

  • Is There Money to be Made in These Medical Drug Stocks?

    By Ali Ghorbanzadeh - September 9, 2012 | Tickers: LLY, FRX, OPK, PFE

    In this unstable economic climate, finding ways to outperform the market is much easier said than done. However, one screening tool that has proven to be effective in determining whether a stock is moving higher is insider buying due to one simple reason: they buy stocks, just like us, to make more money. In addition, they arguably have the best view of the company being a part of the day-to-day more »

  • When Stock is Falling with the CEO Buying Millions of Shares, Investors Should Follow

    By Jonathan Yates - August 22, 2012 | Tickers: BSX, DOLE, OPK, SFD, TSN

    Investing legend Peter Lynch has stated that there are many factors that result in insiders selling shares of a company stock, but only one for buying.  Reasons to sell, according to Lynch, who guided the Fidelity Magellan mutual fund to annualized returns of 29.2% from 1977 to 1990, could include the need for cash to buy a home or pay tuition.  The insider selling could also be part of more »

  • Are these Stocks Worth Buying as Well?

    By Ali Ghorbanzadeh - August 15, 2012 | Tickers: IMAX, MRK, OPK, RGC

    Investors are always on the hunt to find stocks that outperform the general market. In these turbulent times, that is much easier said than done. One screening tool that has proven to be effective in determining whether a stock is moving higher is insider buying due to one simple reason: they buy stocks to make more money. In addition, they arguably have the best view of the company being a more »

  • 4 Stocks Insiders are Buying

    By Meena Krishnamsetty - July 26, 2012 | Tickers: IMAX, NAV, OPK, OSK, VHI

    Tracking insider information is one of the most well-established ways to profit from the stock market. A number of empirical studies have shown that non-routine insider activity beats the broader market by about 7 percent. Additionally, insider activity can give you some level of guidance on a stock that does not have wide analyst coverage. I picked some stocks below that recently saw insider purchasing activity to see how they more »

  • Why are Insiders Buying Opko Health?

    By Soroush Pour - July 12, 2012 | Tickers: MDT, OPK, SYK, WAT

    In the financial world, there are many reasons corporate insiders would choose to sell their company’s stock, but only one reason they would choose to buy.  Over the past decade, there has been a flood of empirical research – Lakonishok in 2001, Jeng in 2003, and Metrick in 2003 – focused on determining the profitability of insider trading. 

    Interestingly, each study discovered a statistically significant correlation between insider purchases and abnormal more »

  • Should We Follow the Smart Money into these Stocks?

    By Ali Ghorbanzadeh - July 9, 2012 | Tickers: AMGN, CSCO, OPK, PFE, SONS

    In this volatile and unsettling market, finding ways to outperform the market is much easier said than done. However, one screening tool that has proven to be effective in determining whether a stock will move higher is insider buying due to one simple reason: they buy stocks, just like us, to make more money. In addition, they arguably have the best view of the company being a part of the more »

  • Are These Stocks Worthy of Your Portfolio?

    By Ali Ghorbanzadeh - June 26, 2012 | Tickers: XCO, MRK, OPK

    As many investors know, finding ways to outperform the market is much easier said than done. However, one screening tool that has proven to be effective in determining whether a stock is moving higher is insider buying due to one simple reason: they buy stocks, just like us, to make more money. In addition, they arguably have the best view of the company being a part of the day-to-day operations more »

  • Page 1 of 2